Kraton (NYSE:KRA) was downgraded by equities research analysts at TheStreet from a “b-” rating to a “c+” rating in a research note issued on Monday.

Other equities analysts also recently issued reports about the company. UBS Group increased their target price on Kraton from $38.00 to $39.00 and gave the stock a “sell” rating in a research report on Thursday, July 26th. ValuEngine downgraded Kraton from a “sell” rating to a “strong sell” rating in a report on Friday, October 26th. SunTrust Banks downgraded Kraton from a “buy” rating to a “hold” rating in a report on Friday, October 26th. Zacks Investment Research downgraded Kraton from a “hold” rating to a “sell” rating in a report on Thursday, October 18th. Finally, Loop Capital set a $76.00 price objective on Kraton and gave the stock a “buy” rating in a report on Wednesday, August 15th. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $57.50.

NYSE KRA opened at $26.83 on Monday. Kraton has a twelve month low of $26.72 and a twelve month high of $53.99. The stock has a market cap of $864.12 million, a P/E ratio of 9.41 and a beta of 1.78. The company has a current ratio of 2.33, a quick ratio of 1.04 and a debt-to-equity ratio of 2.11.

Kraton (NYSE:KRA) last released its earnings results on Wednesday, October 24th. The specialty chemicals company reported $1.02 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.21 by ($0.19). Kraton had a return on equity of 14.83% and a net margin of 5.87%. The business had revenue of $523.11 million for the quarter, compared to analysts’ expectations of $528.00 million. On average, equities analysts anticipate that Kraton will post 3.16 EPS for the current year.

In other news, insider Stephen E. Tremblay sold 13,085 shares of the firm’s stock in a transaction dated Thursday, September 20th. The stock was sold at an average price of $49.50, for a total value of $647,707.50. Following the transaction, the insider now directly owns 102,409 shares in the company, valued at approximately $5,069,245.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Kevin Michael Fogarty sold 27,748 shares of the firm’s stock in a transaction dated Friday, September 21st. The stock was sold at an average price of $50.00, for a total value of $1,387,400.00. Following the completion of the transaction, the chief executive officer now owns 273,281 shares in the company, valued at $13,664,050. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,007 shares of company stock worth $2,489,221. Company insiders own 3.70% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Xact Kapitalforvaltning AB grew its stake in shares of Kraton by 24.2% in the second quarter. Xact Kapitalforvaltning AB now owns 5,644 shares of the specialty chemicals company’s stock valued at $260,000 after buying an additional 1,100 shares in the last quarter. James Investment Research Inc. grew its stake in shares of Kraton by 1.9% in the second quarter. James Investment Research Inc. now owns 62,820 shares of the specialty chemicals company’s stock valued at $2,899,000 after buying an additional 1,185 shares in the last quarter. Strs Ohio grew its stake in shares of Kraton by 5.6% in the second quarter. Strs Ohio now owns 22,700 shares of the specialty chemicals company’s stock valued at $1,047,000 after buying an additional 1,200 shares in the last quarter. United Services Automobile Association grew its stake in shares of Kraton by 20.7% in the second quarter. United Services Automobile Association now owns 7,189 shares of the specialty chemicals company’s stock valued at $332,000 after buying an additional 1,234 shares in the last quarter. Finally, Rhumbline Advisers grew its stake in shares of Kraton by 1.8% in the second quarter. Rhumbline Advisers now owns 75,780 shares of the specialty chemicals company’s stock valued at $3,496,000 after buying an additional 1,316 shares in the last quarter. Institutional investors and hedge funds own 97.35% of the company’s stock.

Kraton Company Profile

Kraton Corporation manufactures and sells styrenic block copolymers and other engineered polymers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Polymer and Chemical. The Polymer segment offers performance products, including styrene-butadiene-styrene and styrene-isoprene-styrene; and specialty polymers, such as hydrogenated styrenic block copolymers, as well as isoprene rubber and isoprene rubber latex for use in medical and personal care products, adhesives, tackifiers, paints, and coatings.

Further Reading: Growth Stocks

Receive News & Ratings for Kraton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kraton and related companies with MarketBeat.com's FREE daily email newsletter.